welcome to ois@asrs 2016
Published 7 years ago • 48 plays • Length 7:59Download video MP4
Download video MP3
Similar videos
-
29:00
how do strategics view retina opportunities? (ois@asrs 2016)
-
8:04
aerpio therapeutics: focus on tie2 activation (ois@asrs 2016)
-
5:36
tmi raising money to convert destructive macrophage (ois@asrs 2016)
-
14:58
catch up on ois@aao’s year in review (ois@aao 2016)
-
4:24
allegro ophthalmics: first-in-class anti-integrin agent (ois@asrs 2016)
-
8:06
ois co chair bill link wraps up ois@asrs (ois@asrs 2016)
-
22:20
retina experts serve up a combination platter at ois@asrs (ois@asrs 2016)
-
4:47
bausch lomb shares developments in vitrectomy (ois@asrs 2016)
-
7:44
retina 2019 and beyond - ocutrx vision technologies at ophthalmology innovation summit @ aao 2019
-
27:57
ois podcast episode #334: early stage retina drug development financing
-
37:42
retinal gene therapy 2018 at ophthalmology innovation summit retina - ois
-
7:45
opthea: targeting a more complete blockade of vegf (ois@asrs 2016)
-
5:38
graybug could file gb-102 ind next year (ois@asrs 2016)
-
6:56
ocular therapeutix: intravitreal depot technology for retinal drug delivery (ois@asrs 2016)
-
12:28
saxton looks for early stage opportunities (ois@asrs - 2016)
-
8:36
genentech’s adamis speaks on ophthalmology’s importance and a professional hero (ois@asrs 2016)
-
5:59
regeneron: pursuing combination therapies with pdgfr-beta and ang2 (ois@asrs 2016)
-
17:17
what were the highlights of ois@asrs?
-
6:05
alimera sciences: addressing dme with persistent microdose therapy (ois@asrs 2016)
-
41:58
ois podcast episode #302:finding and funding assets in retina, from ois retina@asrs
-
4:37
pr3vent presentation on groundbreaking developments in ai & imaging at ois@asrs 2019